Companies: 48,874 Total Market Cap: 132460447025120.92

Healius Limited

ASX-HLS
Healthcare Diagnostics & Research
Rank #13545
Market Cap 499.32 M
Volume 1.92 M
Price 0.69
Change (%) 1.39%
Country or region Australia Australia

Healius Limited's latest marketcap:

499.32 M

As of 05/19/2025, Healius Limited's market capitalization has reached $499.32 M. According to our data, Healius Limited is the 13545th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 499.32 M
Revenue (ttm) 1.15 B
Net Income (ttm) -14,721,276
Shares Out 726.13 M
EPS (ttm) -0.02
Forward PE 1165.01
Ex-Dividend Date 05/09/2025
Earnings Date 05/21/2025
Market Cap Chart
Data Updated: 05/19/2025

Healius Limited's yearly market capitalization.

Healius Limited has seen its market value drop from A$2.32 B to A$773.33 M since 2020, representing a total decrease of 66.71% and an annual compound decline rate (CAGR) of 22.19%.
Date Market Cap Change (%)
05/19/2025 A$773.33 M -20.44%
12/31/2024 A$994.80 M -16.2%
12/29/2023 A$1.19 B -32.22%
12/30/2022 A$1.75 B -43.13%
12/31/2021 A$3.08 B 32.57%
12/31/2020 A$2.32 B

Company Profile

About Healius Limited

Healius Limited is a leading provider of specialty diagnostic services in Australia, catering to both consumers and healthcare practitioners. The company delivers a comprehensive range of diagnostic solutions through its well-established network of facilities.

Business Segments

  • Pathology: Offers private medical laboratory and pathology services.
  • Imaging: Provides diagnostic imaging services.
  • Others: Includes additional healthcare-related services.

Brand Portfolio

Healius operates under several trusted brands, including:

  • Laverty Pathology
  • Dorevitch Pathology
  • QML Pathology
  • Western Diagnostic Pathology
  • Genomic Diagnostic
  • Vetnostics
  • TML Pathology
  • Abbott Pathology
  • IQ Pathology
  • Kossard
  • Gastrolab
  • Agilex Biolabs

Operations

The company manages an extensive network of:

  • Medical laboratories
  • Medical centers
  • Patient collection centers
  • Community imaging centers

Corporate Background

Originally incorporated in 1994 as Primary Health Care Limited, the company rebranded to Healius Limited in December 2018. Headquartered in Sydney, Australia, Healius continues to expand its diagnostic and healthcare services nationwide.

Frequently Asked Questions

As of 05/19/2025, Healius Limited (including the parent company, if applicable) has an estimated market capitalization of $499.32 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Healius Limited global market capitalization ranking is approximately 13545 as of 05/19/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region Australia
Founded 1994
IPO Date n/a
Employees 9,658
CEO Paul Anderson
Sector Healthcare
Industry Diagnostics & Research
Address 161 Castlereagh Street
Sydney, Victoria 2000
Australia
Website https://www.healius.com.au
People Also Watch
TMO
413.92 1.39%
Danaher
196.41 1.39%
Lonza Group AG
687.27 1.39%
IDXX
521.68 1.39%